Advertisement
Screener

QUAKER CHEMICAL CORPORATION (KWR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

1.8 / 5 stars · 44/120 Roast Me

QUAKER CHEMICAL CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

QUAKER CHEMICAL CORPORATION (KWR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-23

  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2015-03-31 was $200.00K.
  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $100.00K, a 97.22% decline from fiscal 2023.
  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $3.60M, a 350.00% increase from fiscal 2022.
  • QUAKER CHEMICAL CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $800.00K, a 70.37% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed
2025-12-31$100.00K
10-K · filed 2026-02-23
2024-12-31$100.00K
10-K · filed 2026-02-23
2023-12-31$3.60M
10-K · filed 2026-02-23
2022-12-31$800.00K
10-K · filed 2025-02-24
2021-12-31$2.70M
10-K · filed 2024-02-29
2020-12-31$6.50M
8-K · filed 2023-08-03
2019-12-31$2.50M
10-K · filed 2022-03-01
2018-12-31$2.00M
10-K · filed 2021-03-01
2017-12-31$3.40M
10-K · filed 2020-03-20
2016-12-31$2.90M
10-K · filed 2019-02-28
2016-03-31$0.00
10-Q · filed 2016-04-27
2015-12-31$900.00K
10-K · filed 2018-02-28
$852.00K
10-K · filed 2016-02-25
2015-03-31$200.00K
10-Q · filed 2016-04-27
2014-12-31$1.10M
10-K · filed 2017-02-28
$1.14M
10-K · filed 2015-02-26
2013-12-31$2.24M
10-K · filed 2016-02-25
2012-12-31$5.88M
10-K · filed 2013-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
VALVOLINE INC (VVV)United States$3.618B49.71